Abstract
Study of crystal and molecular structures offers detailed pictures of intermolecular interactions in the solid state. These serve as exemplars for the understanding of intermolecular interactions in the disordered phases of the liquid state and solution. Properties and reactivity of chemical species and systems are axiomatically related to their structure. One of the most important and active areas of structural study concerns molecular complexation. The concept of structural complementarity underlies a wide range of chemical and biological topics embracing antigen-antibody interactions, enzyme-substrate and enzyme-inhibitor interactions, and host-guest relationships, many with potential and application among the separation sciences. One of the oldest of the physical separation methods with a history of practical exploitation is the use of diastereomeric complexes for (partial) resolution of enantiomeric mixtures (Pasteur, 1853). The traditional method takes advantage of the differential solubility of the complexes in an appropriately chosen solvent. Since the less-soluble phase separates from solution usually as a crystalline solid leaving the more-soluble phase in solution, the less-soluble phase is a molecular assembly with macroscopic properties palpably different from its diastereomeric relative. And so it is not surprising that together with the lower solubilities, one finds higher heats of solution, heats of fusion and fusion points for the less-soluble phases (Jacques, Collet & Wilen, 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Banfield, C and Rowland, M. Stereospecific high-pressure Chromatographic analysis of warfarin in plasma. Journal of Pharmaceutical Sciences, 72, 921–928 (1983).
Brock, C. P., Schweizer, W. B. and Dunitz, J. D. On the validity of Wallach’s rule. On the the density and stability of racemic crystals compared with their chiral counterparts. Journal of the American Chemical Society 115, 9811–20 (1991).
Bush, E. B. and Trager, W. F. High yield synthesis of warfarin and its phenolic metabolites new compounds. Journal of Pharmaceutical Sciences 72, 830–831 (1983).
Carter, O. L., McPhail, A. T. and Sim, G. A. Optically active organometallic compounds. Configuration of (−)−l, l’-dimethylferrocene-3-carboxylic acid through x-ray analysis of its quinidine salt. Journal of the Chemical Society Section A, 365-373 (1967).
Carter, S. D. & Wallace, T. W. 2-Methoxy-6-methylbenzaldehyde and related compounds. Synthesis 1983, 999-1002.
Cheng, C. C. Structure and sntimalarial activity of amionoalcohols and 2-(p-chlorophenyl)-2-(4-piperidyl)tetrahydrofuran. Journal of Pharmaceutical Sciences 60, 1596–1598 (1971).
Collet, A. and Jacques, J. Etude des melanges d’antipodes potiques. V.-Acides mandeliques substitues. No. 630. Bulletin de la Societe Chimique de France 12, 3330–3334 (1973).
Dijkstra, G. D. H., Kellogg, R. M., Wynberg, H., Svendsen, J. S., Marko, L, and Sharpless, K. B. Conformational study of cinchona alkaloids. A combined NMR, molecular mechanics, and x-ray approach. Journal of the American Chemical Society 111, 8069–8076 (1989).
Doherty, R., Benson, W. R., Maienthal, M. and Stewart, J. McD. Crystal and molecular Structure of quinidine. Journal of Phamaceutical Sciences 67, 1698–1700 (1978).
Etter, M. C. Hydrogen bonds as design elements in organic chemistry. Journal of Physical Chemistry 95, 4601–4610 (1991).
Etter, M., MacDonald, J. C. and Bernstein, J. Graph-set analysis of hydrogen bond patterns. Acta Crystallographica B46, 256–262 (1990).
Frydenvang, K., Hjelvan, G., Jensen, B. and Do Rosario, S. M. M. Structures of choline in different crystal surroundings. Acta Crystallographica B40, 280–288 (1984).
Gilman, B. (-Editor) Mandelic acid, in “Organic Synthesis, Collective Volume I”, 2nd Ed. pp 336–340, Wiley, New York, NY (1956).
Gould, R. O. and Walkinshaw, M. D. Molecular recognition in model crystal complexes: The resolution of D and L amino acids. Journal of the American Chemical Society 108, 7840–7842 (1984).
Gould, R. O. Kelly, R. and Walkinshaw, M. D. Asymmetric resolution and molecular recognition. Part 1. The crystal structure of N-benzoyl-L-alanyl-strychninium dihydrate. Journal of the Chemical Society Perkin Transaction II, 847-852 (1985).
van der Haest, A. D. Wynberg, H., Leusen, F. J. J. and Bruggink, A. Toward a rational design of resolving agents. Part II. Correlation between resolution results and physical properties of diastereomeric salts. Recueil des Travaux Chimiques des Pays-Bas 109, 523–528 (1990).
Hiskey, C. F., Bullock, E., and Whitman, G. Spectrophotometric study of aqueous solutions of warfarin sodium. Journal of Pharmaceutical Sciences 51, 43–46 (1962).
Ikawa, M., Stahmann, M. A. & Link, K. P. Studies on 4-hydroxycoumarins. V. The condensation of α,β-unsaturated ketones with 4-hydroxycoumarin. Journal of Organic Chemistry 66, 902–906 (1944).
Jaworski, C. and Hartung, W. H. Amino alcohols. XII. Optical isomers in the ephedrine series of compounds. Journal of Organic Chemistry 8, 494–504 (1943).
Jacques, J., Collet, A. and Wilen, S. H. “Enantiomers, Racemates, and Resolutions”, John Wiley & Sons, New York, NY (1981).
Jeffrey, G. A. & Saenger, W. (1991) “Hydrogen Bonding in Biological Structures”, Springer-Verlag, New York, NY.
Jeyaraj, G. L. and Porter, W. R. New method for the resolution of racemic warfarin and its analogues using low-pressure liquid chromatogrgaphy. Journal of Chromatography 315, 378–383 (1984).
Johnson, R. L. and Jones, L. A. Preparation of m-and p-substituted benzalacetones, 2-phenylcyclopropyl methyl ketones and benzylacetones. Journal of Chemical and Engineering Data 16, 112–115 (1971).
Leusen, F. J. J., BruinsSlot, H. J. B., Noordik, J. H., van der Haest, A. D. Wynberg, H., and Bruggink, A. Toward a rational design of resolving agents. Part IV. Crystal packing analyses and molecular mechanics calculations for five pairs of diastereomeric salts of ephedrine and a cyclic phosphoric acid. Recueil des Travaux Chimiques des Pays-Bas 111, 111–118 (1992).
Kachino S. and Masao H. Structure of quinidine, C20H24N2O2. Acta Crystallographica C39,310–312 (1983).
Karle, I. and Karle, J. Anomalous dispersion of sulfur in quinidine sulfate (C20H25N2O2)2SO4.2H2O, implications for structure analysis. Proceedings of the National Academy of Sciences (U. S. A.) 78, 5938–41 (1981).
Oleksyn, B. J. The role of molecular geometry in the biological activity of cinchona alkaloids and related compounds, in “Molecular Structure and Biological Activity”. Elsevier Science Publishing Co., Inc., Amsterdam, The Netherlands, pp. 181-191(1982).
O’Reilly, R. A. Studies of the optical enantiomorphs of warfarin in man. Clinical Pharmacological Therapeutics 16, 348–354 (1974)
Pasteur, L. (Tartaric acids). Comptes Rendes Academie de Sciences 37, 162 (1853).
Platt, L. O., Jr. Synthesis, resolution, and chiroptical properties of some 4’-substituted warfarins. Honors Essay, Oral Roberts University, Tulsa, OK (1987).
Ruggiero, G., Thaggard, A. L., Valente, E. J., and Eggleston, D. S. Structural variations in 3,4-dihydro-2H-pyran ketals: Acyl and aryl warfarin derivatives. Acta Crystallographica B46, 629–637 (1990).
Savell, Jr., V. H. Synthesis and spectroscopic properties of compounds related to warfarin. Honors Thesis, Mississippi College, Clinton, MS (1987).
Sheldrick, G. M. “SHELXS-86”, Acta Crystallographica A46, 467–473 (1990).
Stella, V. J., Mooney, K. G., and Pipkin, J. D. Dissolution and ionization of warfarin. Journal of Pharmaceutical Sciences 73, 946–948, (1984).
Sellers, E. M. Interaction of Warfarin Stereoisomers with human albumin. Pharmacology Research Communications 7, 331–336 (1975).
Trager, W. F., Lewis, R. J. and Garland, W. A. Mass Spectral Analysis in the Identification of Human Metabolites of Warfarin. Journal of Medicinal Chemistry 13, 1196–1204 (1970).
Trager, W. F. in “Drug Metabolism Concepts. ACS Symposium Series. No. 44”, D. M. Jerina, Ed., American Chemical Society, Washington DC, 1977, Chapter 5.
Valente, E. J., Zubkowski, J. D., and Eggleston, D. S. Discrimination in resolving systems: ephedrine-mandelic acid. Chirality 4, 494–504 (1992).
Valente, E. J., Miller, C. W., Zubkowski, J. D., Shui, X. and Eggleston, D. S. Discrimination in resolving systems. II. Ephedrine-substituted mandelic acid. Chirality 7, 652–676 (1995).
West, B. D., Preis, S., Schroeder, C. H., and Link, K. P. Studies on the 4-Hydroxycoumarins. XVII. The resolution and absolute configuration of warfarin. Journal of the American Chemical Society 83, 2676–2679 (1961).
Westley, J. W., Evans, R. H. and Blount, J. F. Optical resolution of asymmetric amines by preferential crystallization of lasalocid salts. Journal of the American Chemcial Society 99, 6057 (1977).
Wheeler, C. R. and Trager, W. F. Absolute configuration of acenocoumarin. Journal of Medicinal Chemistry 22, 1122–1124 (1979).
Wheeler, C. R. Warfarin and phenprocoumon as probes to distinguish inducible forms of cytochrome P-450. Doctoral Dissertation, University of Washington, Seattle, WA (1980).
Wilen, S. H. “Tables of Resolving Agents and Optical Resolutions”, University of Notre Dame Press, Notre Dame, Indiana (1972).
Wynberg, H. Asymmetric catalysis by alkaloids. Topics in Stereochemistry 16, 87–129 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Valente, E.J., Ruggiero, G., Miller, C.W., Zubkowski, J.D., Eggleston, D. (1997). Diastereomeric Discrimination: Structural Aspects. In: Perry, D.L. (eds) Materials Synthesis and Characterization. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0145-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0145-3_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0147-7
Online ISBN: 978-1-4899-0145-3
eBook Packages: Springer Book Archive